Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Nebulized AER101 to Inhibit Glycolysis for Pre-Operative Non-small Cell Lung Cancer (NSCLC)

NCT07631299 is registered in ClinicalTrials.gov with University of Oklahoma as lead sponsor.

NCT NCT07631299
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07631299 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Nebulized AER101 to Inhibit Glycolysis for Pre-Operative Non-small Cell Lung Cancer (NSCLC)
Lead sponsor
University of Oklahoma
Phase
Phase 1
Overall status
Not yet recruiting
Start date
June 30, 2026
Completion date
June 30, 2027
Enrollment
5 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

non-small cell lung cancer stage i, non-small cell lung cancer stage ii